Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis

Adi Wilf-Yarkoni*, Itay Lotan, Israel Steiner, Mark A. Hellmann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis'. Together they form a unique fingerprint.

Medicine & Life Sciences